Health and Fitness Health and Fitness
Thu, October 27, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Bull & Lifshitz, LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Declares A 20-Cent Fourth-Quarter 2011 Dividend
[ Thu, Oct 27th 2011 ] - Market Wire
Crystal Research Associates, LLC Issues Executive .. al Overview (EIO) on Adamis Pharmaceuticals Corp.
[ Thu, Oct 27th 2011 ] - Market Wire
FMX Ventures Inc. and Tolima Gold Corp. Announce .. or and Commencement of Private Placement Offering
[ Thu, Oct 27th 2011 ] - Market Wire
Cannabis Science Releases First Cannabis-Extract- .. Now at Cannabis Therapeutics, 957 E. Fillmore St,
[ Thu, Oct 27th 2011 ] - Market Wire
Health Net Federal Services Launches Mobile Site .. he-Go Access to Health Care for Military Families
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec und Portola Pharmaceuticals verknden .. rogramm fr den oral verabreichten SYK-Inhibitor b
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec et Portola Pharmaceuticals annoncent .. ns le cadre daun programme dainhibiteur oral de l
[ Thu, Oct 27th 2011 ] - Market Wire
Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific
[ Thu, Oct 27th 2011 ] - Market Wire
Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector
[ Thu, Oct 27th 2011 ] - Market Wire
PharmaGap Sets Time for in Vivo Tests
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Reports Third Quarter 2011 Financial Results
[ Thu, Oct 27th 2011 ] - Market Wire
Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs
[ Thu, Oct 27th 2011 ] - Market Wire
Implant Sciences Explosives Detection Technology Protects Major European Bank
[ Thu, Oct 27th 2011 ] - Market Wire
Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)
[ Thu, Oct 27th 2011 ] - Market Wire
ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)
[ Thu, Oct 27th 2011 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011
[ Thu, Oct 27th 2011 ] - Market Wire
Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu
Wed, October 26, 2011
[ Wed, Oct 26th 2011 ] - Market Wire
CardioNet, Inc. Board of Directors Announces the .. gnation of Randy Thurman as Chairman of the Board
[ Wed, Oct 26th 2011 ] - Market Wire
OncoGenex Announces Publication of OGX-427 Pre-Clinical Data in Pancreatic Cancer
[ Wed, Oct 26th 2011 ] - Market Wire
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
[ Wed, Oct 26th 2011 ] - Market Wire
FDA Schedules Delcath Pre-New Drug Application Meeting Date
[ Wed, Oct 26th 2011 ] - Market Wire
DURECT Corporation Invites You to Join its Third Quarter 2011 Earnings Conference Call
[ Wed, Oct 26th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Adolor Corp.
[ Wed, Oct 26th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of HealthSpring, Inc.
[ Wed, Oct 26th 2011 ] - Market Wire
AtriCureas Synergy Ablation System Receives a Recommendation from FDA Expert Advisors
[ Wed, Oct 26th 2011 ] - Market Wire
Biogen Idec maakt positieve top-line resultaten b .. zoek naar BG-12 (dimethylfumaraat) oraal voor mul
[ Wed, Oct 26th 2011 ] - Market Wire
Universal American Corp. Reports Third Quarter 2011 Results
[ Wed, Oct 26th 2011 ] - Market Wire
Critical Outcome Technologies Inc. Reports Fiscal 2012 First Quarter Financial Results
[ Wed, Oct 26th 2011 ] - Market Wire
Baxter to Present at the Credit Suisse 2011 Healthcare Conference

Baxter to Present at the Credit Suisse 2011 Healthcare Conference


Published on 2011-10-26 13:27:18 - Market Wire
  Print publication without navigation


DEERFIELD, Ill.--([ BUSINESS WIRE ])--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Credit Suisse 2011 Healthcare Conference on Wednesday, November 9, 2011, at 11:00 a.m. (CT) or 12:00 p.m. (ET).

The live webcast of Baxteras presentation can be accessed from the Baxter corporate website at [ www.baxter.com ] and will be available for replay through December 8, 2011.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.

Contributing Sources